LESSONS LEARNED AT THE INTERFACE OF MEDICINE AND PSYCHIATRY
The Psychiatric Consultation Service at Massachusetts General Hospital (MGH) sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. Such consultations require the integration of medical and psychiatric knowledge. During their thrice-weekly rounds, Dr. Huffman and Dr. Stern discuss the diagnosis and management of conditions confronted. These discussions have given rise to rounds reports that will prove useful for clinicians practicing at the interface of medicine and psychiatry. 
I
readily confused with the signs and symptoms of depression? How can one determine whether unusual convulsive symptoms are manifestations of true seizure activity or psychogenic episodes?
Neuropsychiatric sequelae of cerebrovascular accidents (CVAs) are common and varied. The presented case highlights aspects of the neuropsychiatric evaluation of a poststroke patient with mood symptoms and unusual seizure-like activity. The discussion that follows will clarify several important diagnostic issues. An annotated bibliography is included for those interested in learning more about this topic.
Case Presentation
Ms. A, a 40-year-old, heavily tattooed woman with a history of bipolar disorder and alcohol dependence, was rushed to the hospital from jail after she wrapped a cord around her neck in a suicide attempt. During her evaluation in the Emergency Department (ED), she was awake, alert, irritable, and minimally cooperative. A computerized tomographic (CT) scan of the head revealed low-density abnormalities in the left frontal, parietal, and occipital lobes consistent with venous infarctions (secondary to the hypoxia sustained during her hanging). While in the ED, Ms. A had a number of seizure-like episodes (with clonic, jerking activity in her upper extremities). The medical team felt that these episodes were unlike tonic-clonic seizures seen in other patients; when they placed these symptoms in the context of Ms. A's angry and provocative manner, the team suspected pseudoseizures.
What Neuropsychiatric Manifestations Occur Commonly After Stroke?
Poststroke depression is a common psychiatric complication of stroke. Approximately 20% of patients who sustain a stroke meet criteria for major depressive disorder in the poststroke period; another 20% meet criteria for minor depression following stroke. Rapid diagnosis and treatment of poststroke depression are crucial, as rehabilitative efforts in the days following a stroke are critical in the overall functional recovery of poststroke patients. Left untreated, episodes of poststroke depression last for months and even years. Patients who have poststroke depression appear to have less ability to participate in their rehabilitation, and some studies 1, 2 suggest that poststroke depression leads to a worsened longterm functional outcome.
A number of psychosocial risk factors appear to increase the likelihood of developing poststroke depression. These include a history of major depression, poststroke social isolation, living alone, and, possibly, a family history of major depression. In addition, the risk of developing poststroke depression also appears to correlate with the severity of physi-cal disability resulting from the stroke. Other variables, including cognitive impairment, age, and gender, have not been consistently associated with the development of poststroke depression.
Poststroke anxiety is also common; approximately one fourth of poststroke patients meet criteria (except for duration criteria) for generalized anxiety disorder (GAD) in the poststroke period. This poststroke anxiety is also associated with decreased functional recovery, which can persist for years after the stroke. Patients with GAD in the acute poststroke period appear to have decreased abilities to perform activities of daily living (ADLs) when compared to poststroke patients without anxiety. Poststroke mania occurs less frequently; it develops in less than 1% of poststroke patients. Symptoms of poststroke mania are similar to those of primary mania.
Another neuropsychiatric manifestation of stroke is a "catastrophic reaction," a collection of symptoms (involving intense desperation and frustration) that is uncharacteristic of the patient's prestroke personality. This occurs in roughly 10% of poststroke patients and is strongly associated with poststroke depression as well as a personal and family history of psychiatric disorders.
Finally, pseudobulbar affect, a clinical syndrome involving frequent and easily provoked spells of emotion (typically manifest by laughing and crying), is seen in approximately 10% to 15% of poststroke patients. In its most common form, brief fits of crying or laughing occur with appropriate changes in mood; in more serious cases, crying or laughing may develop in situations inappropriate to the context.
Is There a Correlation Between Lesion Location and the Development of Poststroke Neuropsychiatric Sequelae?
Possibly. Controversy exists with regard to the correlation between lesion location and poststroke depression. Initially it was thought that the frontal lobes and a right parietal location were most frequently associated with poststroke depression. However, more recent analyses (including a large meta-analysis by Carson and coworkers 3 ) have found no correlation between lesion location and poststroke depression. If there is a correlation between stroke location and the presence of poststroke depression, it appears that strokes of the left frontal cortex and left basal ganglia are most often associated with the development of poststroke depression.
Anxiety associated with poststroke depression is most often seen with left-sided lesions, while patients with isolated anxiety may more often have right-hemispheric lesions. Poststroke mania appears to occur most often with right hemispheric lesions, especially when they occur in the right orbitofrontal region or the right thalamus. Catastrophic reactions are strongly associated with left frontal strokes.
How Are Poststroke Mania and Depression Treated?
Poststroke affective disorders are treated in roughly the same way as primary affective disorders. Selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), stimulants, and electroconvulsive therapy (ECT) have all been effective in the treatment of poststroke depression. SSRIs may be the first-line treatment of poststroke depression, given that they do not carry the risk of orthostatic hypotension and cardiac conduction abnormalities associated with TCAs. In one double-blind study by Robinson and associates, 4 however, nortriptyline was found to be both well-tolerated and superior to fluoxetine in the treatment of poststroke depression; therefore, TCAs should also be strongly considered for treatment of poststroke depression.
Psychostimulants have also been efficacious for treatment of poststroke depression. Given the importance of adequate rehabilitative efforts in the immediate poststroke period, the ability of these agents to act more rapidly than traditional agents makes them very attractive in the treatment of poststroke depression. Stroke itself is not a contraindication to stimulant use. However, because one is essentially giving the patient a mild cardiac stress test with stimulants, conditions such as uncontrolled hypertension, recent ventricular arrhythmia, tachycardia, or recent myocardial infarction would be relative contraindications to the use of stimulants. In addition, stimulants should also be avoided in patients who have a history of an adverse reaction to stimulants, who are concomitantly taking monoamine oxidase inhibitors (MAOIs), or who are psychotic. Newer antidepressants with effects on norepinephrine (e.g., venlafaxine or mirtazapine)
have not yet been studied in patients with poststroke depression. However, other agents that affect norepinephrine, such as nortriptyline and psychostimulants, have been effective in the treatment of poststroke depression without causing adverse effects as a result of noradrenergic stimulation.
Controlled studies of poststroke mania have yet to be completed, although case reports have suggested that lithium, valproic acid, carbamazepine, clonidine, and neuroleptics may each be effective in the treatment of poststroke mania. 5 Given that there is some evidence that anticonvulsant mood stabilizers may be superior to lithium in the treatment of secondary mania, and given the propensity for seizures in the poststroke period, mood stabilizing anticonvulsants may be the agents of choice in this population. Adjunctive neuroleptics and/or benzodiazepines can also be used while the dose of the anticonvulsant is being titrated upward.
Does Ms. A's History of Bipolar Disorder Make It More Likely That She Will Develop Mania?
The answer is unclear. It appears that patients who develop poststroke mania are more likely to have premorbid depression, as well as higher rates of a family history of affective illness. Therefore, it is quite likely that a history of bipolar disorder would increase the risk of poststroke mania; however, conclusive data are not yet available.
Given the Neuroanatomic Distribution of Ms. A's Stroke, What Neurologic Deficits Might Be Expected?
A left frontal lesion can disrupt usual frontal functions. Difficulties with executive function (manifested as difficulty with clock-drawing and other tasks involving planning, organizing, and sequencing), perseveration, disinhibition, and apathy are possible manifestations. Language areas, specifically Broca's area, may also be affected and result in a Broca's aphasia (with intact comprehension, but with impaired repetition and fluency, resulting in socalled telegraphic speech).
A left parietal lesion may affect reading, writing, and calculation. Gerstmann's syndrome, manifest by dyscalculia, finger agnosia, left-right disorientation, and dysgraphia, is a classic manifestation of left parietal lesions, although it is rarely seen in its full form. If the lesion is left temporoparietal, it may affect Wernicke's area (left superior posterior temporal lobe) and result in an aphasia, with impaired comprehension and repetition, and intact "fluency" that consists of phrases or sentences that are out of context or nonsensical.
A left occipital lesion may affect right-sided visual fields and may result in dyslexia without dysgraphia.
How Might One Make the Diagnosis of Pseudoseizures in Ms. A?
Pseudoseizures have the following characteristics that may differentiate them from true seizures: It should be kept in mind that many individuals with pseudoseizures also have true seizure disorders. Moreover, many seizures (e.g., complex partial seizures) often have unusual manifestations (e.g., perceptual disturbances and sudden panic) and may not result in abnormalities on a standard EEG, even during the event. Therefore, one should carefully assess the possibility of true seizures in this patient, especially given her recent stroke.
If further observation and treatment of Ms. A suggest that pseudoseizures are present, a number of steps can be taken to relieve her suffering and reduce the frequency of her episodes. The clinician should explore with Ms. A the relationship between her psychosocial distress and the onset of her seizure-like episodes. It could be that these episodes are her body's way of telling her that she is under inordinate amounts of stress. The clinician can share his or her impression that such symptoms are likely to resolve over time, especially if she is able to express her emotions and to reduce her stress and distress. Referral to psychiatry should also be considered, not only to help with the treatment of her symptoms, but also to assess and treat comorbid depression and anxiety, which occur frequently among those with pseudoseizures. Unfortunately, there are no specific pharmacologic treatments for pseudoseizures; however, antidepressants and anxiolytics can alleviate the manifestations of comorbid psychiatric illness. 351-359 -A study of 104 depressed patients who received nortriptyline, fluoxetine, or placebo for a 12-week study period following stroke. The authors found that patients with poststroke depression treated with nortriptyline had a significantly higher response rate than did those in the other 2 groups. Furthermore, the patients who received nortriptyline had improvements in anxiety and in their ability to complete ADLs when compared to those in the other 2 treatment groups. All treatments were well-tolerated in this study. Wiart L, Petit H, Joseph A, et al. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 2000;31:1829-1837 -A placebo-controlled, double-blind trial of fluoxetine for the treatment of poststroke depression. Thirty-one patients with poststroke depression were enrolled and treated with either fluoxetine or placebo. The group that received fluoxetine had significantly higher response rates (63%) than did the group that received placebo (31%) over the 45-day study period. There were no significant differences in functional, cognitive, or motor improvement between the groups. Fluoxetine was well-tolerated in this small study. These results confirmed prior findings that selective serotonin reuptake inhibitors (e.g., fluoxetine and citalopram) are effective in the treatment of poststroke depression. Carota A, Rossetti AO, Karapanayiotides T, et al. Catastrophic reaction in acute stroke: a reflex behavior in aphasic patients. Neurology 2001;57:1902-1905 -This study evaluated 326 first-time stroke patients for the presence of a catastrophic reaction. The authors found that 12 patients (4%) manifested a catastrophic reaction. All such patients had left-hemispheric strokes, and all had aphasia. The presence of catastrophic reaction was closely correlated to the presence of poststroke depression; 75% of the patients who had catastrophic reactions also had poststroke depression.
